Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

Article  PubMed  Google Scholar 

Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47–53.

Article  PubMed  PubMed Central  Google Scholar 

Gong Y, Jiang Q, Zhai M, Tang T, Liu S. Thyroid cancer trends in China and its comparative analysis with G20 countries: projections for 2020–2040. J Glob Health. 2024;14:04131.

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16:17–29.

Article  PubMed  Google Scholar 

Mulla M, Schulte KM. Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the central compartment. Clin Endocrinol. 2012;76:131–6.

Article  Google Scholar 

Yoshihara A, Noh JY, Watanabe N, Kunii Y, Suzuki M, Matsumoto M, et al. Characteristics of patients with graves’ disease whose thyroid hormone levels increase after substituting potassium iodide for methimazole in the first trimester of pregnancy. Thyroid. 2020;30:451–6.

Article  CAS  PubMed  Google Scholar 

Omi Y, Yanagida J, Yoshida Y, Horiuchi K, Okamoto T. Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography? Endocr J. 2024;71:357–62. https://doi.org/10.1507/endocrj.EJ1523-0413.

Yang Z, Wang X, Tao T, Zou J, Qiu Z, Wang L, et al. Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study. BMC Surg. 2023;23:325.

Article  PubMed  PubMed Central  Google Scholar 

Yu J, Deng Y, Liu T, Zhou J, Jia X, Xiao T, et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun. 2020;11:4807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren W, Zhu Y, Wang Q, Song Y, Fan Z, Bai Y, et al. Deep learning prediction model for central lymph node metastasis in papillary thyroid microcarcinoma based on cytology. Cancer Sci. 2023;114:4114–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eun NL, Son EJ, Kim JA, Gweon HM, Kang JH, Youk JH. Comparison of the diagnostic performances of ultrasonography, CT and fine needle aspiration cytology for the prediction of lymph node metastasis in patients with lymph node dissection of papillary thyroid carcinoma: a retrospective cohort study. Int J Surg. 2018;51:145–50.

Article  PubMed  Google Scholar 

Moma CA, Barreto IS, Assumpção LVM, Zantut-Wittmann DE. Predominance of CD4+ T cells in metastatic cervical lymph nodes in papillary thyroid carcinoma. Endocr Connect. 2024;3:e240135. https://doi.org/10.1530/EC-24-0135.

Amanullah M, Pan M, Lu K, Pan X, Lu Y, Luo D, et al. Tumor-infiltrating immune cell landscapes in the lymph node metastasis of papillary thyroid cancer. Curr Oncol. 2023;30:2625–41.

Article  PubMed  PubMed Central  Google Scholar 

Yu Y, Guo X, Chai J, Han Z, Ji Y, Sun J, et al. Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation. Front Oncol. 2023;13:1181325.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park SJ, Kang YE, Kim JH, Park JL, Kim SK, Baek SW, et al. Transcriptomic analysis of papillary thyroid cancer: a focus on immune-subtyping, oncogenic fusion, and recurrence. Clin Exp Otorhinolaryngol. 2022;15:183–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maansson CT, Helstrup S, Ebert EBF, Meldgaard P, Sorensen BS. Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small cell lung cancer patients. Transl Lung Cancer Res. 2023;12:14–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stensgaard S, Thomsen A, Helstrup S, Meldgaard P, Sorensen BS. Plasma immune proteins and circulating tumor DNA predict the clinical outcome for non-small-cell lung cancer treated with an immune checkpoint inhibitor. Cancers. 2023;15:5628. https://doi.org/10.3390/cancers15235628.

Pan Y, Xu M, Chong TH, Xie S, Huang K, Wang G, et al. Combined detection of inflammatory proteins is beneficial for diagnosing the papillary thyroid carcinoma and nodular goiter. iMetaOmics. 2024;1:e14.

Article  Google Scholar 

Cheng KJ, Mejia Mohammed EH, Khong TL, Mohd Zain S, Thavagnanam S, Ibrahim ZA. IL-1α and colorectal cancer pathogenesis: enthralling candidate for anti-cancer therapy. Crit Rev Oncol Hematol. 2021;163:103398.

Article  PubMed  Google Scholar 

Pretre V, Papadopoulos D, Regard J, Pelletier M, Woo J. Interleukin-1 (IL-1) and the inflammasome in cancer. Cytokine. 2022;153: 155850.

Article  CAS  PubMed  Google Scholar 

Krishnamohan M, Kaplanov I, Maudi-Boker S, Yousef M, Machluf-Katz N, Cohen I, et al. Tumor cell-associated IL-1α affects breast cancer progression and metastasis in mice through manipulation of the tumor immune microenvironment. Int J Mol Sci. 2024;25:3950.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao SJ, Ma HS, Liu GM, Gao Y, Wang W. Increased IL-1α expression is correlated with bladder cancer malignant progression. Arch Med Sci. 2023;19:160–70.

CAS  PubMed  Google Scholar 

Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, et al. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Mol Cancer. 2022;21:190.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parsaeian SF, Asadian F, Karimi-Zarchi M, Setayesh S, Javaheri A, Tabatabaie RS, et al. A meta-analysis for association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 polymorphisms with susceptibility to cervical carcinoma. Asian Pac J Cancer Prev. 2021;22:3419–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang W, Dang S, Zhang G, He H, Wen X. Genetic polymorphisms of IL-10, IL-18 and IL12B are associated with risk of non-small cell lung cancer in a Chinese Han population. Int Immunopharmacol. 2019;77:105938.

Article  CAS  PubMed  Google Scholar 

Nozhat Z, Hedayati M. PI3K/AKT pathway and its mediators in thyroid carcinomas. Mol Diagn Ther. 2016;20:13–26.

Article  CAS  PubMed  Google Scholar 

Pacifico F, Leonardi A. Role of NF-kappaB in thyroid cancer. Mol Cell Endocrinol. 2010;321:29–35.

Article  CAS  PubMed  Google Scholar 

Schubert L, Mariko ML, Clerc J, Huillard O, Groussin L. MAPK pathway inhibitors in thyroid cancer: preclinical and clinical data. Cancers. 2023;15:710.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bo J, Mao S, Yang J, Wang L, Zheng J, Zhang C, et al. Rhodiolin inhibits the PI3K/AKT/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer. Phytomedicine. 2024;132:155804.

Article  CAS  PubMed  Google Scholar 

Zhang J, Ren G, Huang T, Sang Y, Zhong Y, Yi Y. miRNA-363-3p hinders proliferation, migration, invasion and autophagy of thyroid cancer cells by controlling SYT1 transcription to affect NF-κB. Endocr Metab Immune Disord Drug Targets. 2024;24:153–62.

Article  CAS  PubMed  Google Scholar 

Hicks HM, Nassar VL, Lund J, Rose MM, Schweppe RE. The effects of aurora kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies. Cancer Biol Ther. 2024;25:2332000.

Article  PubMed  PubMed Central  Google Scholar 

Nitschke K, Worst TS, von Rhade SM, Thaqi B, Neuberger M, Wessels F, et al. High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer. Urol Oncol. 2021;39:499.e491-499.e498.

Article  Google Scholar 

McCuaig S, Barras D, Mann EH, Friedrich M, Bullers SJ, Janney A, et al. The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer. Clin Cancer Res.